Citigroup reduced its price objective for ProKidney, with stock changes and ratings reported by Benzinga and MarketBeat.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup reduced its price objective for ProKidney, with stock changes and ratings reported by Benzinga and MarketBeat.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
Related events
- Citigroup and Barclays lowered their price targets on Equifax stock, while MarketBeat provided a consensus rating.
- Citigroup boosted its price target and gave a buy rating for Wholesale Club, with MarketBeat providing consensus data.
- Citigroup trimmed its price objective for Domino's Pizza, while MarketBeat and Benzinga reported on the research.
- Citigroup reduced its price objective for Morgan Stanley stock on October 18, 2026.
- Citigroup lifted its price target and gave a buy rating for Timken Company, with MarketBeat providing consensus data.